1. Home
  2. CDT vs OST Comparison

CDT vs OST Comparison

Compare CDT & OST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • OST
  • Stock Information
  • Founded
  • CDT 2019
  • OST 2010
  • Country
  • CDT United States
  • OST China
  • Employees
  • CDT N/A
  • OST N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • OST Industrial Machinery/Components
  • Sector
  • CDT Health Care
  • OST Technology
  • Exchange
  • CDT Nasdaq
  • OST Nasdaq
  • Market Cap
  • CDT 5.2M
  • OST 4.3M
  • IPO Year
  • CDT N/A
  • OST 2022
  • Fundamental
  • Price
  • CDT $0.69
  • OST $1.54
  • Analyst Decision
  • CDT
  • OST
  • Analyst Count
  • CDT 0
  • OST 0
  • Target Price
  • CDT N/A
  • OST N/A
  • AVG Volume (30 Days)
  • CDT 1.4M
  • OST 22.9K
  • Earning Date
  • CDT 05-13-2025
  • OST 01-27-2025
  • Dividend Yield
  • CDT N/A
  • OST N/A
  • EPS Growth
  • CDT N/A
  • OST N/A
  • EPS
  • CDT N/A
  • OST N/A
  • Revenue
  • CDT N/A
  • OST $32,463,213.00
  • Revenue This Year
  • CDT N/A
  • OST N/A
  • Revenue Next Year
  • CDT N/A
  • OST N/A
  • P/E Ratio
  • CDT N/A
  • OST N/A
  • Revenue Growth
  • CDT N/A
  • OST N/A
  • 52 Week Low
  • CDT $0.65
  • OST $1.42
  • 52 Week High
  • CDT $350.00
  • OST $5.78
  • Technical
  • Relative Strength Index (RSI)
  • CDT 31.97
  • OST 30.61
  • Support Level
  • CDT $0.65
  • OST $1.43
  • Resistance Level
  • CDT $1.05
  • OST $2.35
  • Average True Range (ATR)
  • CDT 0.14
  • OST 0.16
  • MACD
  • CDT 0.07
  • OST -0.03
  • Stochastic Oscillator
  • CDT 7.30
  • OST 11.96

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About OST Ostin Technology Group Co. Ltd.

Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.

Share on Social Networks: